In patients with hypertension, angiotensin-converting enzyme inhibitors (ACEIs) did not reduce the risk of age-related macular degeneration (AMD) compared with calcium channel blockers (CCBs). Several ...

A potential association between the use of angiotensin-receptor blockers (ARBs) and angiotensin-converting–enzyme (ACE) inhibitors and the risk of coronavirus disease 2019 (Covid-19) has not been well ...

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers are antihypertensive medicines used to treat high blood pressure. While the enzyme inhibitors work by reducing the level of ...

ACEI and ARB use in CKD has been available for over three decades, but it is still underutilized. Now, a new clinical ...

Neoadjuvant bevacizumab treatment for colorectal liver metastasis: A retrospective study. Preoperative chemoradiotherapy for locally advanced rectal adenocarcinoma: A dosimetric comparison of ...

There is concern about the potential of an increased risk related to medications that act on the renin–angiotensin–aldosterone system in patients exposed to coronavirus disease 2019 (Covid-19), ...